Idriss Djilai-Saiah

Dr. Idriss Djilai-Saiah


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2016 in Canadian Journal of Gastroenterology and Hepatology
Verified
Journal Article
Open access
PDF file
MSM. Cristina P. de Souza
M. Cristina P. de Souza
MDMarie-Eve Deschênes
Marie-Eve Deschênes
SLSuzanne Laurencelle
Suzanne Laurencelle
PGPatrick Godet
Patrick Godet
CRClaude C. Roy
Claude C. Roy
IDIdriss Djilai-Saiah
Idriss Djilai-Saiah
The question about recommending pure, noncontaminated oats as part of the gluten-free diet of patients with celiac disease remains controversial. This might be due to gluten cross contamination and to the possible immunogenicity of some oat cultivars. In view of this controversy, a review of the scientific literature was conducted to highlight the latest findings published between 2008 and 2014 to examine the current knowledge on oats safety and celiac disease in Europe and North America. Results showed that regular oats consumed in Canada are largely contaminated. Overall, the consumption of pure oats has been generally considered to be safe for adults and children. However, it appears that some oat cultivars may trigger an immune response in sensitive individuals. Therefore, further long-term studies on the impact of consumption of oats identifying the cultivar(s) constitute an important step forward for drawing final recommendations. Furthermore, a closer and more accurate monitoring of the dietary intake of noncontaminated oats would be paramount to better determine what its actual contribution in the gluten-free diet of adults and children with celiac disease are in order to draw sound recommendations on the safety of pure oats as part of the gluten-free diet.

1 May 2013 in Journal of Autoimmunity
Verified
Journal Article
Closed access
SCSylvie Chabot
Sylvie Chabot
AFAmin Fakhfakh
Amin Fakhfakh
KBKathie Béland
Kathie Béland
ALAlain Lamarre
Alain Lamarre
MOMichael B.A. Oldstone
Michael B.A. Oldstone
IDIdriss Djilai-Saiah
Idriss Djilai-Saiah

11 August 2016 in Autoimmunity
Verified
Journal Article
Closed access
SCSylvie Chabot
Sylvie Chabot
FAFernando Alvarez
Fernando Alvarez
AAAbdelaziz Amrani
Abdelaziz Amrani
IDIdriss Djilai-Saiah
Idriss Djilai-Saiah
Identifying the type of diabetogenic CD8+ T cells that initiate autoimmune diabetes (AID) is a critical step in designing appropriate strategies for the early detection of beta cell-directed autoimmunity and its progression to diabetes. We generated a novel double transgenic (Tg) mouse model on the naturally diabetes resistant C57Bl/6 background, co-expressing two transgenes including a specific TCR anti-lymphocytic choriomeningitis virus nucleoprotein (LCMV-NP) carried by CD8+ T cells and LCMV-NP (as neo-self antigen) expressed by pancreatic beta cells. The resulting double Tg mouse showed partial thymic deletion of the NP-specific CD8+ T cells. The escaping autoreactive NP-specific CD8+ T cells joining the periphery were activated and gained effector functions. Both male and female mice mounted anti-NP antibodies, but only one-fourth adult males spontaneously developed AID. Significant upregulation of the CD44 and CD122 markers as compared to healthy male and female mice characterized the phenotype of diabetogenic CD8+ T cells in diabetic male mice. We also show that only 10% of these CD8+  T cells expressed programmed death 1 receptor (PD-1). Together, these results suggest that in our double Tg mouse model, Ag-specific effector CD44+CD122+PD-1−CD8+ T cell subpopulation is associated with the pathogenesis of AID.